Several CXCR4 antagonists have already been synthesized (e.g., AMD3100 (plerixafor), AMD3465, TF 14016, BMS-936564), which display a high anti-proliferative capacity both in vitro and in different animal tumor models [14]. Here, CXCR4 is linked to neoplasm.